Clinical Trial Update: A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor [Phase 4]

View source ↗

Summary

A Phase 4 cross-over pilot study evaluating abobotulinum toxin A (Dysport) for task-dependent upper limb tremor is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tremor Limb

Drugs mentioned

• abobotulinum toxin A (abobotulinum toxin A)

Snippet

Sponsor: David M. Simpson | Conditions: Tremor, Limb | Phase 4 | Status: RECRUITING